Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,233 | 1,673 | -1,354 | -2,341 | -31,877 |
| Depreciation Amortization | 3,452 | 3,367 | 3,474 | 3,337 | 5,037 |
| Income taxes - deferred | 469 | -757 | -474 | 682 | -99 |
| Accounts receivable | 3,233 | -391 | 2,238 | -2,748 | 1,865 |
| Accounts payable and accrued liabilities | -1,024 | -478 | -83 | 1,229 | -1,352 |
| Other Working Capital | 5,206 | -1,564 | 2,349 | -297 | -212 |
| Other Operating Activity | -2,060 | 7,352 | 5,905 | 8,494 | 31,833 |
| Operating Cash Flow | $16,509 | $9,202 | $12,055 | $8,356 | $5,195 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,372 | -1,308 | -1,452 | -2,382 | -1,076 |
| Net Acquisitions | -20,764 | -752 | -5,089 | -1,118 | N/A |
| Other Investing Activity | -164 | -568 | -11 | -281 | 0 |
| Investing Cash Flow | $-22,300 | $-2,628 | $-6,552 | $-3,781 | $-1,076 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,900 | 1,650 | 12,281 | N/A | N/A |
| Debt Repayment | -3,674 | -7,920 | -9,807 | -5,521 | -8,018 |
| Common Stock Issued | 271 | 911 | 722 | 235 | 225 |
| Common Stock Repurchased | -2,404 | -2,596 | N/A | N/A | N/A |
| Other Financing Activity | -1,308 | 0 | -166 | 0 | 0 |
| Financing Cash Flow | $9,785 | $-7,955 | $3,030 | $-5,286 | $-7,793 |
| Exchange Rate Effect | -1,104 | -3,125 | -80 | 691 | -422 |
| Beginning Cash Position | 13,698 | 18,204 | 9,751 | 9,771 | 13,867 |
| End Cash Position | 16,588 | 13,698 | 18,204 | 9,751 | 9,771 |
| Net Cash Flow | $2,890 | $-4,506 | $8,453 | $-20 | $-4,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,509 | 9,202 | 12,055 | 8,356 | 5,195 |
| Capital Expenditure | -1,376 | -1,308 | -1,452 | -2,382 | -1,100 |
| Free Cash Flow | 15,133 | 7,894 | 10,603 | 5,974 | 4,095 |